BioRestorative Therapies, Inc. (BRTX) › Gross ProfitBioRestorative Therapies, Inc. (BRTX) — Gross ProfitAnnual figures by fiscal year, from SEC filings.2011: $02012: $14.3K2013: $1.5K2014: $202.2K2015: $367.4K2016: $36.3K2017: $81.0K2023: $145.8K2024: $372.9K2025: $335.9K$335.9K2011Gross Profit (USD)2025Fiscal YearGross ProfitChange YoY2025$335.9K-9.9%2024$372.9K+155.8%2023$145.8K—2017$81.0K+123.4%2016$36.3K-90.1%2015$367.4K+81.7%2014$202.2K+13633.8%2013$1.5K-89.7%2012$14.3K—2011$0—Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share